China Medical & HealthCare Group (ex - COL CAPITAL // ex - China Online) - Facts - Älteste Beiträge zuerst

[Ace]

Hallo liebe China Online-Gemeinde!

Der Name unseres "Long-Investments" hat sich nach mehr als acht Jahren geändert. Mal wieder Grund genug, um ein bisschen aufzuräumen und einen neuen Thread ins Leben zu rufen.

Als wir Ende der Neunziger in diesen Wert investierten, lag unsere Hoffnung darin, dass alle Chinesen über China Online in die vernetzte Welt eintauchen. Hat nicht ganz geklappt.
Spätestens mit der ersten Namensänderung in COL Capital wurde dann deutlich, dass sich unser Chinese in ein Beteiligungsunternehmen verwandelt hat. Auch wenn der Wert alter Tage nicht mehr erreichbar schien - obwohl der Kurs eine Aktie nach damaligem Verständnis doch nie unter 0,01 EUR fallen konnte - , gab es doch regelmäßg attraktive Dividenden und sogar einen Spin-Off.

Der Kurs ist in der letzten Zeit wieder auf das Niveau der Neunziger gesprungen und plötzlich haben wir (scheinbar) ein Medizinunternehmen im Depot.

Die bereits im Dezember veröffentlichte Nachricht dazu ist hier im Board total an uns vorbei gegangen. Daher zur Vervollständigung:

COL Capital Limited to be renamed as China Medical & HealthCare Group Limited, with New Leadership Team, New Strategic Partner, and New Funds
Dr Lim Cheok Peng and Dr Jonathan Seah, together with CM International Holding Pte. Ltd., partner to tap China's multi-billion dollar healthcare and elderly care market

HONG KONG, Dec 17, 2015 - (ACN Newswire) - The shareholders of COL Capital Limited ("the Company" stock code: 383) has approved the proposed change of its name to China Medical & HealthCare Group Limited at a Special General Meeting this week. The change reflects the Company's new focus on China's lucrative healthcare and elderly care market to enhance value for its shareholders. The Company also announced yesterday the designation and appointment of industry veterans Dr Lim Cheok Peng as Chairman and Dr Jonathan Weiyan Seah as CEO of the Company respectively. They will lead a new management team to run the Company's portfolio of healthcare and elderly care related businesses including existing hospitals and a retirement village, with the aim of establishing a network of integrated facilities across China.

The shareholders of the Company at the Special General Meeting has also approved the issue of consideration shares for the acquisitions which will increase the Company's existing stakes in their hospital and retirement village businesses (the "Acquisitions").

CM International Holding Pte. Ltd. ("CMIH"), a subsidiary of China Minsheng Investment Corp., Ltd., recently entered into a HK$900 million share subscription with the Company, and also separately entered into an MOU to establish a joint venture fund management company with the Company.

Dr Lim Cheok Peng, Chairman of the Company, said, "The outlook for the private healthcare sector in the PRC is increasingly positive due to favourable demographics such as an aging population and a growing middle class, supportive government policies, and low penetration of private healthcare institutions, especially in the second and third-tier cities. These factors will provide tremendous opportunities for us."

McKinsey predicts that healthcare spending in China will reach US$1 trillion in 2020, up from US$350 billion in 2014, and it is estimated that by 2050, the elderly population in China will total 400 million, accounting for one-third of the country's population.

The Acquisitions

With the completion of the Acquisitions announced yesterday, the Company will now own 100 percent of Lianyungang Jiatai Construction Co. Ltd. ("Jiatai") and approximately 70 percent of Aveo China (Holdings) Limited ("Aveo China"). The approximately remaining 30 percent of Aveo China will continue to be held by Aveo Healthcare Limited, part of the Aveo Group Limited group of companies. Aveo Group is a leading owner, operator and manager of retirement communities across Australia.

Jiatai engages in the investment, management, and operations of healthcare and hospital businesses, the trading of medical equipment and related supplies, and property development in the PRC. It currently owns three operating hospitals located in Nanjing, Kunming and Yunnan, and two vacant land parcels for medical and healthcare purposes adjacent to the Nanjing and Kunming hospitals.

Aveo China is engaged in developing and managing elderly care and retirement communities in the PRC. It has developed its first project in Shanghai which is a comprehensive elderly care village consisting of 868 independent living units, about 270 to 280 service apartments, an elderly nursing home, a medical center and a commercial area comprising a shopping mall, retail shops, a fitness center, and recreational facilities. The first residents of this village are expected to move in later this month.

The Designation and New Appointment

The Board of the Company believes that Dr Lim and Dr Seah's experience and expertise will bring operational and strategic value.

Dr Lim Cheok Peng - Chairman and Non-Executive Director
With more than 25 years of international experience in the healthcare sector, Dr Lim has extensive experience both as a medical practitioner and in developing and managing hospital businesses. He was previously the managing director and executive director, and later the senior advisor, of Kuala Lumpur and Singapore-listed IHH Healthcare Berhad ("IHH"), the world's second-largest listed healthcare operator by market capitalisation. Prior to that, Dr Lim held vice chairman, executive vice chairman and managing director roles at Singapore-listed Parkway Holdings Limited ("Parkway"), one of the region's largest integrated private healthcare groups, before it became part of IHH.

Dr Jonathan Weiyan Seah - CEO and Executive Director
Dr Seah holds an MBA from Harvard Business School, and has more than 20 years of experience in clinical medicine, investment banking, private equity and general management. Dr Seah was previously the founding CEO of Parkway's China division - ParkwayHealth China, one of the largest operators of international medical centers in China. Before joining Parkway he was a medical doctor in Singapore, and an investment banker with Merrill Lynch in the USA.

Strategic Partnership with CMIH

The Company recently announced a HK$900 million share subscription by CMIH or its nominee, and that it has also separately entered into an MOU with CMIH to establish a joint venture fund management company. The proposed joint venture will create a fund to invest in healthcare, elderly care and related companies, including operators of clinics, check-up centres and hospitals in the Greater China region. The Board is excited about the strategic partnership and believes the share subscription will strengthen its capital base. Proceeds from the share subscription are to be used for the expansion and working capital of the Company's hospital, healthcare and elderly care businesses and to reduce debt.

Mr Laurence Liao, CEO of CMIH, said, "It has always been our intention to invest in quality companies with outstanding management within fast-growing sectors. It is one of CMIH's corporate strategies to invest to help facilitate the development of the Chinese economy, and the healthcare and elderly care sectors are among the most important areas. We are excited about our investment in the Company and working together with Dr Lim and Dr Seah, and look forward to tapping this large market together with them."

Dr Jonathan Seah, CEO of the Company, concluded, "We are delighted at this opportunity to bring together existing operating assets, an experienced management team, a strong strategic partner, and new financial resources, to develop an integrated platform for China's multi-billion dollar healthcare and elderly care market."

Enquiries:
Strategic Financial Relations Limited
Ingrid Cheng Tel: [phone] Email: [e-mail]
Cindy Lung Tel: [phone] Email: [e-mail]
Antonio Yu Tel: [phone] Email: [e-mail]
www.sprg.asia



Dec 17, 2015 10:51 HKT/SGT
Topic: Press release summary
Sectors: Financial, Business, Healthcare
http://www.acnnewswire.com
From the Asia Corporate News Network


Ich wünsche uns weiterhin ein lebhaften Informationsaustausch und natürlich einen positiven Kursverlauf unserer China On... Medical & HelathCare Group.

Beste Grüße
Ace

[Dangerous]

die Aveo-Aktivitäten sind ein guter Schritt. Auch die chinesische Gesellschaft überaltert. In den Bereich Altenpflege einzusteigen, ist ein gelungener Schritt. Hoffentlich auch mit so profitablen Marge wie in DT

[Magreta]

Hallo,
gibt es noch Neugierige, die den Kurs hier verfolgen?
Scheint so, als würde unser Invest ein wenig auf der Stelle treten, oder?

[prego_1]

Heute ca. 20% Plus. Warum auch immer.
https://www.hkex.com.hk/eng/invest/company/quote_page_e.asp?…

Eine Depotleiche erwacht!!
In drei Jahren fast 1000% Plus.
Nicht schlecht!

[Ace]

Antwort auf Beitrag Nr.: 52.738.471 von prego_1 am 01.07.16 09:15:59

Habe festgestellt, dass der Kurs immer dann extrem in die Höhe geht, wenn ich mal nicht täglich gucke...

[durran]

Antwort auf Beitrag Nr.: 52.758.859 von Ace am 04.07.16 15:01:44

Sieht sehr gut aus. VollesPetential auf 10€ zu steigen innerhalb der nächsten 5 Jahre.
Medical Markt in China wird explodieren.Diehatten schon immer ein sehr gutes Händchen.

[piapatti]

Antwort auf Beitrag Nr.: 53.577.942 von durran am 28.10.16 21:04:39

Was meint IHr: LOhnt sich hier noch der Einstieg ? Verfolge den Wert jetzt ca. 9 Monate und sehe hier noch weitere Kurschancen. Wie fallen die Analystenmeinungen zu diesem Wert aus und wo seht ihr den Wert ?

[Ace]

Homepage

Hier ist es ja richtig ruhig geworden ...

In den letzten Wochen hat sich der Kurs der Aktie bei positivem Marktumfeld schleichend nach unten entwickelt. Ob das darauf zurückzuführen ist, dass es keine interessante Story für internationale Investoren mehr gibt?
Ich muss zugeben: Inwieweit Krankenhäuser unbegrenztes Wachtumspotential versprechen, weiß ich auch noch nicht.

Die Homepage ist auf jedenfall mal einen Blick wert. Deutlich besser aufgebaut als zu COL-Zeiten.
http://www.cmhg.com.hk/en/

Beste Grüße
Ace

[Schmusekätzchen]

Naja, das kann man jetzt sehen wie man(n) will, aber Frauen haben eben ab und an eine andere Sichtweise und diese läßt mich fragen, wie woll die diese Zinslast stemmen. Aber lest am besten selbst die aktuelle Bekanntmachung von China Medical & HealthCare Group von heute, Di. 27.06.2017, bzw. - um formal korrekt zu bleiben - von gestern, Mo. 26.06.2017 NACH Handelsschluss:

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take
no responsibility for the contents of this announcement, make no representation as to its accuracy
or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising
from or in reliance upon the whole or any part of the contents of this announcement.
(Incorporated in Bermuda with limited liability)
(Stock Code: 383)
China Medical & HealthCare Group Limited
SECOND SUPPLEMENTAL AGREEMENT
IN RELATION TO THE LOAN AGREEMENT
The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower
(a non wholly-owned subsidiary of the Company) entered into the Second Supplemental
Agreement pursuant to which the parties agreed to (i) extend the Repayment Date under the
Loan Agreement as amended by the Supplemental Agreement from 23 June 2017 to 23 July
2018 and (ii) amend the interest rate for the first interest period commencing on 23 June 2017
to the date falling one (1) month thereafter to 25.805% per annum and to 12% per annum for
the reminder of the term.
This announcement is made by the board of Directors pursuant to Rule 13.09 and Rule 14.36 of
the Listing Rules.
Unless otherwise stated, definitions used in the Company’s announcements dated 23 December
2015 and 12 January 2017 respectively shall have the same meanings when used in this
announcement.
The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower
(a non wholly-owned subsidiary of the Company) entered into the second supplemental loan
agreement (the “Second Supplemental Agreement”) pursuant to which the parties agreed to
(i) extend the Repayment Date under the Loan Agreement as amended by the Supplemental
Agreement from 23 June 2017 to 23 July 2018 and (ii) amend the interest rate for the first
interest period commencing on 23 June 2017 to the date falling one (1) month thereafter to
25.805% per annum and to 12% per annum for the reminder of the term. The Loan has been used
and applied by the Borrower as its general working capital. The terms of the Second Supplemental
Agreement were arrived between the parties after arm’s length negotiation.
– 2 –
The Directors consider that the terms of the Second Supplemental Agreement are fair, reasonable
and beneficial to the Company and are in the interests of the shareholders as a whole.
Save as disclosed herein, all other terms and conditions of the Loan Agreement as amended by
the Supplemental Agreement remain unchanged.
By Order of the Board
China Medical & HealthCare Group Limited
Dr. Lim Cheok Peng
Chairman
Hong Kong, 26 June 2017
As at the date of this announcement, the Board comprises: -
Executive Directors
Ms. Chong Sok Un (Deputy Chairman), Dr. Jonathan Weiyan Seah (Chief Executive Officer),
Dato’ Wong Peng Chong and Mr. Kong Muk Yin
Non-Executive Directors
Dr. Lim Cheok Peng (Chairman) and Mr. Liao Feng
Independent Non-Executive Directors
Mr. Lau Siu Ki, Mr. Zhang Jian and Dr. Xia Xiaoning

[Magreta]

Antwort auf Beitrag Nr.: 55.212.893 von Schmusekätzchen am 27.06.17 11:22:50

Wo geht die Reise hin?

Ich hatte die Ausrichtung China Medical&HealthCa auch eher in Richtung Senioren gesehen.
Dort gibt es in China ein erhebliches Potential. Wäre nur schön, wenn sich dies auch mal im Kurs niederschlägt.